P
Paracel Explorer
Dernière publication·Octobre 2026

Inovelon

Rufinamidum — susp 40 mg/ml

Eisai Pharma AG

ATCN03AF03
Swissmedic62066
Dossier19892
Remboursement
QP 10%
Modifications (10)